Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.08B
+7.3% from 2023
Prescriptions
131K
$15,913.06 per claim
Patients
16K
8,903 prescribers
Total spending, 2024
$2.08B
$132,548.92 per patient
Medicare prescription drug plans paid $2.08B for Jakafi in 2024, for 130,858 prescriptions and refills to 15,707 patients (up 7.3% from 2023). The average cost per claim was $15,913.06.
California had the highest Medicare cost for Jakafi in 2024: $218.6M for 14,098 claims, followed by New York ($166.5M).
Andrew T Kuykendall, internal medicine in Tampa, FL, had the highest Medicare cost for Jakafi in 2024: 381 claims costing $6.9M.
Jakafi is made by Incyte Corporation (INCY), listed in the Medicare spending data as Incyte Corporat.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Andrew T Kuykendall Tampa, FL | Internal Medicine | 381 | 53 | $6.9M |
| Kristen M Kindervater Ann Arbor, MI | Physician Assistant | 376 | 44 | $5.8M |
| Christopher B Benton |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7,984 | 111,081 | 13,482 | $1.76B |
| 2023 | 8,271 | 116,194 | 14,033 | $1.94B |
| 2024 | 8,903 | 130,858 | 15,707 | $2.08B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 343 |
| 44 |
| $5.7M |
| Aaron T Gerds Cleveland, OH | Hematology-Oncology | 272 | 37 | $4.8M |
| Katie L Zellner Milwaukee, WI | Physician Assistant | 329 | 49 | $4.7M |
| Stephen T Oh Saint Louis, MO | Hematology | 236 | 27 | $4.1M |
| Kristen M Pettit Ann Arbor, MI | Hematology | 220 | 33 | $3.5M |
| Maureen Thyne New York, NY | Physician Assistant | 221 | 28 | $3.4M |
| Salman Fazal Harrisburg, PA | Hematology-Oncology | 212 | 28 | $3.4M |
| Elizabeth O Hexner Philadelphia, PA | Hematology-Oncology | 201 | 21 | $3.2M |
| Emily M Parkman Houston, TX | Nurse Practitioner | 189 | 26 | $3.2M |
| Anthony Hunter Atlanta, GA | Hematology | 188 | 26 | $3.0M |
| Misty L Mahaffey Stanford, CA | Nurse Practitioner | 174 | 31 | $2.9M |
| Jeanne M Palmer Scottsdale, AZ | Hematopoietic Cell Transplantation and Cellular Therapy | 164 | 34 | $2.9M |
| Aleksey Aronov New York, NY | Nurse Practitioner | 166 | 42 | $2.8M |
| Meredith L Saylor Boston, MA | Nurse Practitioner | 213 | 37 | $2.8M |
| Pankit J Vachhani Birmingham, AL | Hematology-Oncology | 165 | 17 | $2.8M |
| Wahid T Hanna Knoxville, TN | Hematology-Oncology | 162 | 20 | $2.7M |
| Gabriela S Hobbs Boston, MA | Hematology-Oncology | 173 | 27 | $2.7M |
| Hannah K Choe Columbus, OH | Hematology | 169 | 27 | $2.7M |
| Chieh-Lin Fu Weston, FL | Hematology-Oncology | 152 | 16 | $2.6M |
| Raymond S Hernandez Duarte, CA | Nurse Practitioner | 195 | 28 | $2.6M |
| James K McCloskey II Hackensack, NJ | Hematology-Oncology | 148 | 25 | $2.6M |
| Elizabeth C Stewart Boston, MA | Nurse Practitioner | 180 | 26 | $2.6M |
| Abdulraheem Yacoub Westwood, KS | Hematology-Oncology | 159 | 26 | $2.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Incyte Corporat INCY | 130,891 | $2.08B |